Ratio Examination: Zentalis Pharmaceuticals Inc (ZNTL)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

In the latest session, Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) closed at $1.72 up 1.78% from its previous closing price of $1.69. In other words, the price has increased by $1.78 from its previous closing price. On the day, 0.58 million shares were traded. ZNTL stock price reached its highest trading level at $1.815 during the session, while it also had its lowest trading level at $1.6501.

Ratios:

For a deeper understanding of Zentalis Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.99 and its Current Ratio is at 7.99. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 30 ’25 when Myers Scott Dunseth bought 21,000 shares for $1.40 per share. The transaction valued at 29,373 led to the insider holds 281,192 shares of the business.

Bruns Ingmar bought 20,000 shares of ZNTL for $45,656 on Feb 06 ’25. The Chief Medical Officer now owns 36,629 shares after completing the transaction at $2.28 per share. On Feb 11 ’25, another insider, Cam Gallagher, who serves as the Former Director of the company, bought 687 shares for $2.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 124073072 and an Enterprise Value of -138041024. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.62 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at -5.138 whereas that against EBITDA is 0.81.

Stock Price History:

The Beta on a monthly basis for ZNTL is 1.77, which has changed by -0.47076923 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $5.44, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is 18.38%, while the 200-Day Moving Average is calculated to be -11.62%.

Shares Statistics:

For the past three months, ZNTL has traded an average of 987.55K shares per day and 920970 over the past ten days. A total of 72.14M shares are outstanding, with a floating share count of 57.22M. Insiders hold about 20.68% of the company’s shares, while institutions hold 73.40% stake in the company. Shares short for ZNTL as of 1755216000 were 4462750 with a Short Ratio of 4.52, compared to 1752537600 on 4766727. Therefore, it implies a Short% of Shares Outstanding of 4462750 and a Short% of Float of 7.7199996.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.